|
|
DHS Opens COVID-19 Telehealth Service to Increase Access to COVID-19 Treatment
The Wisconsin Department of Health Services (DHS) has launched a statewide COVID-19 treatment telehealth service. Anyone 18 and older will be able to use free consultation and prescription services to increase access to COVID-19 antiviral treatments. These treatments have been proven to greatly reduce severe illness, hospitalization, and death from COVID-19.
Background: Wisconsin’s COVID-19 treatment telehealth service will provide free, easy access to health care consultation, screening, and prescription for COVID-19 oral antiviral treatments. People who test positive for COVID-19 will be able to use the service to have a video or telephone consultation with a health care clinician. If eligible, the clinician will prescribe oral antiviral pills Paxlovid or Lagevrio. The prescription can be filled at over 600 pharmacies throughout the state. If someone doesn’t have access to a pharmacy DHS can overnight ship the medicine to them.
Eligibility: Wisconsin residents ages 18 and older, regardless of insurance status, who test positive for COVID-19, and must be able to take the antiviral treatment within five days of symptoms starting. At-home COVID tests or tests performed by a health care provider or at a community testing site are acceptable. You will not be asked for proof of a positive test. Even if symptoms are mild, you should seek treatment.
Access: Consultation is available in multiple languages. Residents who do not have access to the internet can access the service by phone. Consultations are available within 30 minutes, seven days a week from 8 a.m. to 8 p.m.
Cost: There is no cost to individuals for use of the service. It is open to all Wisconsinites eligible for COVID-19 treatments regardless of health insurance status.
To learn more about available treatments for COVID-19, visit the DHS website.
COVID-19 by the Numbers
• Cases • Deaths • Disease Activity • Race and Ethnic Disparities • Vaccine
|
|
|
|